Fresenius Medical Care AG (FMS): R&D Expense
Not updated since 2016-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$162.36M
Year ended 2016-12-31
+8.9%
3-year compound annual growth
+7.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2016-12-31 | $162.36M | +15.7% | 2017-02-22, From 2016-01-01 |
| 2015-12-31 | $140.30M | +14.9% | 2017-02-22, From 2015-01-01 |
| 2014-12-31 | $122.11M | -2.9% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $125.81M | +12.7% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $111.63M | +0.7% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $110.83M | +14.8% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $96.53M | +2.9% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $93.81M | +16.9% | 2012-02-23, From 2009-01-01 |
| 2008-12-31 | $80.24M | +20.6% | 2011-03-25, From 2008-01-01 |
| 2007-12-31 | $66.52M | n/a | 2010-02-24, From 2007-01-01 |